Health Care: Drugs

Echo Therapeutics Inc (ECTE: NASDAQ)

$1.644 0.014 | 0.86%
05/31/16 - 11:47 AM ET
Company Profile
Price and Volume
Recent Price 1.63
52 Week High 2.40
52 Week Low 0.88
Avg. Daily Vol. (Mil) 0.04
Beta (3 year) 1.80
Share Related Items
Mkt Cap (Mil) 18.58
Shares Out (Mil) 11.40
Float (Mil) 11.37
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.00
Current Ratio 0.10
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 0.00
Price/Cash Flow -1.20
Per Share Data
Earnings -1.49
Sales 0.00
Book Value 0.00
Cash Flow -1.39
Business Summary
Echo Therapeutics Inc is a medical device company with expertise in skin permeation technology. It develops non-invasive, wireless continuous glucose monitoring system with potential use in the wearable-health consumer & the diabetes outpatient market.
General Information
99 Wood Avenue South
Suite 302
Iselin, NJ 08830
Industry : Drugs
Sector: Health Care
Employees: 17
CEO: Mr. Scott Hollander
Short Interest
Current Month (Mil) 0.20
Previous Month (Mil) 0.18
Short Interest Ratio (Days) 2.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -1,674.60
Return on Investments 346.10
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ECTE

Latest ECTE Headlines from TheStreet

More Financial News for ECTE

Press Releases for ECTE

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter